✦ LIBER ✦

Adjuvant therapy of high-risk malignant melanoma patients with gamma interferon

✍ Scribed by Landthaler, Michael; Braun-Falco, Otto

Book ID: 122397694
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 245 KB
Volume: 20
Category: Article
ISSN: 1097-6787
DOI: 10.1016/S0190-9622(89)80151-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant therapy for patients with high-

Adjuvant therapy for patients with high-risk malignant melanoma

✍ Edward F McClay 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Adjuvant Interferon Therapy for Patients

Adjuvant Interferon Therapy for Patients with Uveal Melanoma at High Risk of Metastasis

✍ Anne Marie Lane; Kathleen M. Egan; David Harmon; Amy Holbrook; John E. Munzenrid 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Systemic Adjuvant Therapy for Patients W

Systemic Adjuvant Therapy for Patients With High-Risk Melanoma

✍ Tsai, Kenneth Y. 📂 Article 📅 2007 🏛 American Medical Association 🌐 English ⚖ 72 KB

Cutaneous melanoma: interferon alpha adj

Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease

✍ Marko Lens 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Cost-effectiveness analysis of interfero

Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain

✍ J.L González-Larriba; S Serrano; M Alvarez-Mon; F Camacho; M.A Casado; J.L Dı́az 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Formation of neutralizing antibodies aga

Formation of neutralizing antibodies against natural interferon-β, but not against recombinant interferon-γ during adjuvant therapy for high-risk malignant melanoma patients

✍ R. Dummer; W. Müller; F. Nestle; J. Wiede; J. Dues; W. Lechner; I. Haubitz; W. W 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB 👁 1 views